Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine Unit

OBJECTİVE: The objective of this study is to identify the annual variations amniocentesis indications such as change in maternal age, cytogenetic results, and other indications. Another outcome is the investigation of the relationship between indications for amniocentesis and the distribution of ch...

Full description

Saved in:
Bibliographic Details
Main Authors: Orkun Çetin, Fatma Ferda Verit Atmaca, Ali Galip Zebitay, Ayşegül Deregözü, Begüm Aydoğan, Seda Keskin, Oğuz Yücel
Format: Article
Language:English
Published: Medical Network 2013-12-01
Series:Gynecology Obstetrics & Reproductive Medicine
Subjects:
Online Access:https://gorm.com.tr/index.php/GORM/article/view/207
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823857344852787200
author Orkun Çetin
Fatma Ferda Verit Atmaca
Ali Galip Zebitay
Ayşegül Deregözü
Begüm Aydoğan
Seda Keskin
Oğuz Yücel
author_facet Orkun Çetin
Fatma Ferda Verit Atmaca
Ali Galip Zebitay
Ayşegül Deregözü
Begüm Aydoğan
Seda Keskin
Oğuz Yücel
author_sort Orkun Çetin
collection DOAJ
description OBJECTİVE: The objective of this study is to identify the annual variations amniocentesis indications such as change in maternal age, cytogenetic results, and other indications. Another outcome is the investigation of the relationship between indications for amniocentesis and the distribution of chromosomal abnormalities. STUDY DESIGN: This study was designed as a retrospective analysis of amniocentesis results of the 1667 pregnant patients between January 2007 and December 2012 in the Süleymaniye Women’s Health Education and Research Hospital. The karyotype results, indications for intervention and complications during procedure were reported. RESULTS: Total chromosome abnormalities were detected in 101 cases out of 1667 patients which correspond to a 6.1% of the total results. Distribution of the chromosomal abnormality detection rate with respect to the amniocentesis indication was 4.2%; in the abnormal first trimester screening tests group; 5.3% in the abnormal second trimester maternal serum screening group, 18.7% in the fetal malformations in previous pregnancy group, and 7.1%. in the abnormal ultrasound findings group. CONCLUSION: Amniocentesis is the most common invasive procedure for prenatal diagnosis. Although the advanced maternal age is still an important indication, there has been significant development of both new markers and technology making this indication for amniocentesis questionable. Prenatal ultrasonography for the soft markers of chromosomal aneuploidy in association with the maternal serum biochemical screening tests should be evaluated during the decision process for amniocentesis.
format Article
id doaj-art-500b76fa7d4d4eb6bbde625b2cca25eb
institution Kabale University
issn 1300-4751
2602-4918
language English
publishDate 2013-12-01
publisher Medical Network
record_format Article
series Gynecology Obstetrics & Reproductive Medicine
spelling doaj-art-500b76fa7d4d4eb6bbde625b2cca25eb2025-02-11T21:22:20ZengMedical NetworkGynecology Obstetrics & Reproductive Medicine1300-47512602-49182013-12-01193145Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine UnitOrkun Çetin0Fatma Ferda Verit Atmaca1Ali Galip Zebitay2Ayşegül Deregözü3Begüm Aydoğan4Seda Keskin5Oğuz Yücel6Süleymaniye Women’s Health Education and Research Hospital, İstanbulSüleymaniye Women’s Health Education and Research Hospital, İstanbulSüleymaniye Women’s Health Education and Research Hospital, İstanbulSüleymaniye Women’s Health Education and Research Hospital, İstanbulŞişli Etfal Education and Research Hospital, İstanbulSüleymaniye Women’s Health Education and Research Hospital, İstanbulSüleymaniye Women’s Health Education and Research Hospital, İstanbul OBJECTİVE: The objective of this study is to identify the annual variations amniocentesis indications such as change in maternal age, cytogenetic results, and other indications. Another outcome is the investigation of the relationship between indications for amniocentesis and the distribution of chromosomal abnormalities. STUDY DESIGN: This study was designed as a retrospective analysis of amniocentesis results of the 1667 pregnant patients between January 2007 and December 2012 in the Süleymaniye Women’s Health Education and Research Hospital. The karyotype results, indications for intervention and complications during procedure were reported. RESULTS: Total chromosome abnormalities were detected in 101 cases out of 1667 patients which correspond to a 6.1% of the total results. Distribution of the chromosomal abnormality detection rate with respect to the amniocentesis indication was 4.2%; in the abnormal first trimester screening tests group; 5.3% in the abnormal second trimester maternal serum screening group, 18.7% in the fetal malformations in previous pregnancy group, and 7.1%. in the abnormal ultrasound findings group. CONCLUSION: Amniocentesis is the most common invasive procedure for prenatal diagnosis. Although the advanced maternal age is still an important indication, there has been significant development of both new markers and technology making this indication for amniocentesis questionable. Prenatal ultrasonography for the soft markers of chromosomal aneuploidy in association with the maternal serum biochemical screening tests should be evaluated during the decision process for amniocentesis. https://gorm.com.tr/index.php/GORM/article/view/207Genetic amniocentesisChromosomal abnormalitiesDetection rate
spellingShingle Orkun Çetin
Fatma Ferda Verit Atmaca
Ali Galip Zebitay
Ayşegül Deregözü
Begüm Aydoğan
Seda Keskin
Oğuz Yücel
Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine Unit
Gynecology Obstetrics & Reproductive Medicine
Genetic amniocentesis
Chromosomal abnormalities
Detection rate
title Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine Unit
title_full Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine Unit
title_fullStr Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine Unit
title_full_unstemmed Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine Unit
title_short Second Trimester Genetic Amniocentesis: Five- Year Experience of a Maternal- Fetal Medicine Unit
title_sort second trimester genetic amniocentesis five year experience of a maternal fetal medicine unit
topic Genetic amniocentesis
Chromosomal abnormalities
Detection rate
url https://gorm.com.tr/index.php/GORM/article/view/207
work_keys_str_mv AT orkuncetin secondtrimestergeneticamniocentesisfiveyearexperienceofamaternalfetalmedicineunit
AT fatmaferdaveritatmaca secondtrimestergeneticamniocentesisfiveyearexperienceofamaternalfetalmedicineunit
AT aligalipzebitay secondtrimestergeneticamniocentesisfiveyearexperienceofamaternalfetalmedicineunit
AT aysegulderegozu secondtrimestergeneticamniocentesisfiveyearexperienceofamaternalfetalmedicineunit
AT begumaydogan secondtrimestergeneticamniocentesisfiveyearexperienceofamaternalfetalmedicineunit
AT sedakeskin secondtrimestergeneticamniocentesisfiveyearexperienceofamaternalfetalmedicineunit
AT oguzyucel secondtrimestergeneticamniocentesisfiveyearexperienceofamaternalfetalmedicineunit